Compare Megapolitan Developments Tbk. (EMDE) vs Organon Pharma Indonesia Tbk. (SCPI) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Megapolitan Developments Tbk. vs Organon Pharma Indonesia Tbk. — how do they compare? Megapolitan Developments Tbk. trades at Rp78 (market cap 264.65B, 4.45M 24h volume), while Organon Pharma Indonesia Tbk. trades at Rp29,000 (market cap 104.4B). The key difference: Megapolitan Developments Tbk. is far larger — about 2.5× Organon Pharma Indonesia Tbk.'s market cap. Which is the better fit depends on your goals.
| EMDE | SCPI | |
|---|---|---|
Market Cap | 264.65B | 104.4B |
Volume | 4.45M | — |
Lot | 44.48K | — |
Turnover | 344.65M | — |
Average Price | 77.48 | — |
Value | 344.65M | — |
Indicative Equilibrium Price | 78 | — |
Indicative Equilibrium Volume | 853 | — |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Megapolitan Developments Tbk.
PT Megapolitan Developments (formerly Megapolitan Developments Corporation) (the Company) was established based on Notary Deed No. 24 dated September 10, 1976 by Soeleman Ardjasasmita, S.H., Notary in Jakarta.
Read more on EMDE →About Organon Pharma Indonesia Tbk.
PT Merck Sharp Dohme Pharma Tbk was established within the frame work of the Foreign Capital Investment Law No. 1 year 1967 as amended by Law No. 11 year 1970 based on Notarial Deed No. 17 dated 7 March 1972 of Djojo Muljadi, S.H. The company originally incorporated as PT. Essex Indonesia, as a joint venture between Schering Corporation, a worldwide, research-based pharmaceutical enterprise headquartered in the United States, and an Indonesian businessman.
Read more on SCPI →
